Kiniksa Pharmaceuticals International Plc (KNSA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 99,271 | 141,078 | 107,954 | 117,828 | 112,567 |
| Marketable Securities | 119,487 | 72,474 | 98,417 | 83,256 | 72,425 |
| Receivables | 20,451 | 15,995 | 21,266 | 3,041 | 24,650 |
| Inventories | 34,858 | 27,278 | 31,122 | 25,583 | 23,958 |
| TOTAL | $301,021 | $270,591 | $276,297 | $256,109 | $246,040 |
| Non-Current Assets | |||||
| PPE Net | 625 | 712 | 734 | 918 | 1,136 |
| Intangibles | 16,750 | 17,000 | 17,250 | 17,500 | 17,750 |
| Other Non-Current Assets | 224,032 | 231,370 | 232,041 | 208,536 | 219,406 |
| TOTAL | $241,407 | $249,082 | $250,025 | $226,954 | $238,292 |
| Total Assets | $542,428 | $519,673 | $526,322 | $483,063 | $484,332 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 7,393 | 5,632 | 8,246 | 1,012 | 648 |
| Accrued Expenses | 63,317 | 44,718 | 44,667 | 41,149 | 35,316 |
| Other current liabilities | 11,484 | 11,427 | 8,193 | 6,430 | 4,596 |
| TOTAL | $84,291 | $64,212 | $63,666 | $53,468 | $47,472 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 12 | 156 | 307 | 2,564 | 4,674 |
| Other Non-Current Liabilities | 11,243 | 11,755 | 11,863 | 12,596 | 13,198 |
| TOTAL | $23,042 | $23,566 | $23,817 | $24,468 | $25,204 |
| Total Liabilities | $107,333 | $87,778 | $87,483 | $77,936 | $72,676 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 71,244 | 70,940 | 70,615 | 70,338 | 70,168 |
| Common Shares | 20 | 20 | 20 | 20 | 19 |
| Retained earnings | -499,562 | -495,654 | -477,950 | -503,187 | -489,332 |
| Other shareholders' equity | -130 | -53 | 6 | -1 | 13 |
| TOTAL | $435,095 | $431,895 | $438,839 | $405,127 | $411,656 |
| Total Liabilities And Equity | $542,428 | $519,673 | $526,322 | $483,063 | $484,332 |